Quick Answer
Xtant Medical Holdings, Inc. reported Operating Income of $7.28 million for fiscal year 2025.
Xtant Medical Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $7.28M | +160.3% |
| 2024 | -$12.07M | -18.9% |
| 2023 | -$10.16M | -50.4% |
| 2022 | -$6.75M | -75.3% |
| 2021 | -$3.85M | -413.2% |
| 2020 | -$751.0K | +66.7% |
| 2019 | -$2.25M | +96.2% |
| 2018 | -$60.08M | -58.8% |
| 2017 | -$37.83M | -401.4% |
| 2016 | -$7.55M | +37.5% |
| 2015 | -$12.08M | -92.8% |
| 2014 | -$6.26M | +30.5% |
| 2013 | -$9.01M | -82.2% |
| 2012 | -$4.94M | +23.3% |
| 2011 | -$6.45M | +25.1% |
| 2010 | -$8.61M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.54M | +167.3% | -45.0% |
| June 30, 2025 | $4.62M | +257.0% | +335.0% |
| March 31, 2025 | $1.06M | +130.6% | +128.1% |
| September 30, 2024 | -$3.78M | -11.6% | -28.2% |
| June 30, 2024 | -$2.95M | -111.8% | +15.1% |
| March 31, 2024 | -$3.47M | -120.2% | -2.5% |
| September 30, 2023 | -$3.38M | -78.2% | -143.4% |
| June 30, 2023 | -$1.39M | -7.0% | +11.7% |
- Xtant Medical Holdings, Inc. showed an increase of +160.3% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, Xtant Medical Holdings, Inc.’s operating income has grown by 184.6% (from -$8.61 million to $7.28 million).
- The most recent figure is from Xtant Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: